ClinConnect ClinConnect Logo
Search / Trial NCT01492595

Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda

Launched by EPICENTRE · Dec 13, 2011

Trial Information

Current as of June 22, 2025

Completed

Keywords

Contact

ClinConnect Summary

Because children with tuberculosis (TB) are usually smear-negative and therefore less infectious, they are generally not considered a public health risk. Up to 70% of children living in the same household with an adult with infectious TB will become infected, and more than 20% of them will develop active TB disease, usually within 12 months. The individual risk of developing disease once infected is highest in children \<5 years. In addition, children under 5 years are at higher risk of developing disseminated forms of TB. The impact of childhood TB is worsened by co-infection with HIV. Con...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Any child who has lived in the same household with the index case continuously for at least 2 weeks within the 3-month period immediately preceding the diagnosis of smear- positive or culture-positive TB in the index case.
  • Informed consent signed by the parent or legal guardian
  • Living within a 2-hour radius of Mbarara town
  • Exclusion Criteria:
  • Child currently receiving anti-tuberculosis treatment
  • Child has received a full course of anti-TB treatment within the last 6 months

About Epicentre

Epicentre is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on infectious diseases and public health, Epicentre leverages its extensive expertise in epidemiology and clinical operations to facilitate the development of effective interventions. Committed to ethical standards and regulatory compliance, Epicentre collaborates with global partners to ensure the successful execution of clinical trials, ultimately contributing to the enhancement of global health initiatives and the well-being of communities worldwide.

Locations

Patients applied

0 patients applied

Trial Officials

Julius Kiwanuka, MD

Principal Investigator

Mbarara University of Science and Technology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials